cardiac-monitoring
(4)
AliveCor
AliveCor is a Mountain View, California digital health company that pioneered the personal, FDA-cleared electrocardiogram (ECG). Its Kardia line of pocket-sized devices lets people record a medical-grade ECG on a smartphone in about 30 seconds, while AI algorithms screen for atrial fibrillation and other arrhythmias. Combining hardware, a subscription care service, and enterprise cardiology programs, AliveCor has recorded well over 160 million ECGs for millions of users and works with clinicians, employers, health systems, and pharmaceutical researchers.
HelpWear
HelpWear is a Toronto-based medical device company building the HeartWatch, a medical-grade ambulatory ECG monitor engineered for extended, continuous wear. Its signature dry-electrode, non-adhesive design avoids the skin irritation that limits traditional adhesive patch monitors, letting patients wear it comfortably for long stretches while it streams clinical-grade heart-rhythm data to physicians. The company targets hard-to-catch conditions like cryptogenic stroke, unexplained syncope and long-term arrhythmia detection, positioning the device as a tool to guide physician decisions and support telemedicine.
Cardiosense
Cardiosense is a Chicago-based health-tech company building an AI platform that turns raw physiological signals into clinical intelligence for heart failure. Its FDA-cleared CardioTag wearable simultaneously captures ECG, PPG and seismocardiogram (SCG) signals, and its machine-learning algorithms estimate pulmonary capillary wedge pressure (PCWP) - a key measure of cardiac filling pressure - noninvasively, so clinicians can spot a worsening heart before it lands a patient in the hospital.
ImaCor, Inc.
ImaCor, Inc. is a New York medical-device company that built the world's first and only hemodynamic transesophageal echocardiography (hTEE) platform for the intensive care unit. Its miniaturized, disposable ClariTEE probe can stay safely in a critically ill patient for up to 72 hours, giving clinicians a continuous, direct window onto the heart - preload, contractility, and right- and left-ventricular function - so they can guide fluids and drugs in real time instead of guessing. In 2022 ImaCor and Clarius Mobile Health launched the FDA-cleared Zura Handheld Hemodynamic Ultrasound, a pocket-sized, 22-ounce TEE system that puts that window in a clinician's hand.